In anecdotal cases of sustained CR to CAR-T therapy in patients with confirmed CD19 negative lymphoma, the achievement of an antitumor effect may be mediated by mechanisms other than CD19 antigen-dependent cytotoxicity, such as “bystander effect” [41,46,53]. This evidence concerns the gene CD19 and lymphoma.